<SEC-DOCUMENT>0001140361-26-006981.txt : 20260226
<SEC-HEADER>0001140361-26-006981.hdr.sgml : 20260226
<ACCEPTANCE-DATETIME>20260226162119
ACCESSION NUMBER:		0001140361-26-006981
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20260226
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260226
DATE AS OF CHANGE:		20260226

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ROCKET PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001281895
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36829
		FILM NUMBER:		26688578

	BUSINESS ADDRESS:	
		STREET 1:		350 FIFTH AVENUE
		STREET 2:		SUITE 7530
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10118
		BUSINESS PHONE:		646-440-9100

	MAIL ADDRESS:	
		STREET 1:		350 FIFTH AVENUE
		STREET 2:		SUITE 7530
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10118

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INOTEK PHARMACEUTICALS CORP
		DATE OF NAME CHANGE:	20040226
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ef20066645_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2025" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:rckt="http://rocketpharma.com/20260226" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2026 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_e3e9eac808264ac2960927de8bc4242a" contextRef="c20260226to20260226" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_acdd86df40cd4b2b8abb1f2b3226cc23" contextRef="c20260226to20260226">0001281895</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="rckt-20260226.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20260226to20260226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001281895</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-02-26</xbrli:startDate><xbrli:endDate>2026-02-26</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">
  <div><span style="font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, DC 20549</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_8710bd8f93954c14ae8d4d83c1765e32" contextRef="c20260226to20260226">8-K</ix:nonNumeric></div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_74990d4afd8b4a26bb3fe5763ea7602b" contextRef="c20260226to20260226" format="ixt:date-monthname-day-year-en">February 26, 2026</ix:nonNumeric></div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_0075e3a30a964b1d923a1e9d4ea4e95c" contextRef="c20260226to20260226">Rocket Pharmaceuticals, Inc.</ix:nonNumeric><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(Exact name of registrant as specified in its charter)</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 33%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_30f7eedfb6ee455f8bf9bab923b106cf" contextRef="c20260226to20260226" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 34%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_f6a54965804945cb98f677ae54b6fda1" contextRef="c20260226to20260226">001-36829</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 33%; vertical-align: middle; font-size: 10pt; font-weight: bold; text-align: center;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_6c732d4f9e434084a4a523c80788826b" contextRef="c20260226to20260226">04-3475813</ix:nonNumeric><br/>
            </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(State or other jurisdiction of incorporation)</div>
            </td>

    <td style="width: 34%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(Commission File Number)</div>
            </td>

    <td style="width: 33%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(IRS Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 49%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_056294b47e544ea8a77dac2bb51c21e2" contextRef="c20260226to20260226">9 Cedarbrook Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_2832b928e97b4a01a14589a7100ee904" contextRef="c20260226to20260226">Cranbury</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_4af64b992fae46208162d2383585a736" contextRef="c20260226to20260226">NJ</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;"><br/>
            </td>

    <td style="width: 49%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_e33554e4daae484a9c37861c175f7873" contextRef="c20260226to20260226">08512</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(</span><span style="font-size: 10pt;">Address of principal
                  executive offices)</span></div>
            </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;"><br/>
            </td>

    <td style="width: 49%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(Zip Code)</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric name="dei:CityAreaCode" id="Fact_f5d628e6546947c985f39da32c2b21de" contextRef="c20260226to20260226">646</ix:nonNumeric>)
        <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_fbde6efd0640486393ea4ee8ce83f4e2" contextRef="c20260226to20260226">440-9100</ix:nonNumeric></div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Not applicable</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(Former name or former address, if changed since last report)</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
        following provisions (see General Instruction A.2):</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 13.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_48917a47bff547a183111e67f5cbd94a" contextRef="c20260226to20260226" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 13.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_7aa612f292a54230b005aee4f5256503" contextRef="c20260226to20260226" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 13.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_ff2482aa341c48ffa578d009fbaafe87" contextRef="c20260226to20260226" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 13.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_38c746b3523b4939af131511deb23496" contextRef="c20260226to20260226" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 41.93%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Title of each class</div>
            </td>

    <td style="width: 13.69%; vertical-align: middle; white-space: nowrap;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Trading</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Symbol(s)</div>
            </td>

    <td style="width: 44.38%; vertical-align: middle; white-space: nowrap;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Name of each exchange on which</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 41.93%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_eb846fb6afed4786a890f4e3485d53f4" contextRef="c20260226to20260226">Common stock, $0.01 par value</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 13.69%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_515feaaf4d554b52aee0dd1ca957b245" contextRef="c20260226to20260226">RCKT</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 44.38%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_7ef7ce52996e424fbf8773bd11c4f080" contextRef="c20260226to20260226" format="ixt-sec:exchnameen">The Nasdaq Global Market</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this
        chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_7120bd16dd83476c9b6a4b196125c36d" contextRef="c20260226to20260226" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new
        or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left;">
<div><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span></div>

        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 2.02.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Results of Operations and Financial Condition.</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On February 26, 2026, Rocket Pharmaceuticals, Inc. (the &#8220;Company&#8221;) announced certain financial information for the quarter and fiscal year ended
        December 31, 2025. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The information in this Item 2.02 and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18
        of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as
        expressly set forth by specific reference in such filing.</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Financial Statements and Exhibits.</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(d) Exhibits.</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 5.13%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="ef20066645_ex99-1.htm">99.1</a></div>
            </td>

    <td style="width: 94.87%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Press Release of Rocket Pharmaceuticals, Inc. dated February 26, 2026.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 5.13%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">104</div>
            </td>

    <td style="width: 94.87%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Cover Page Interactive Data File (embedded within the Inline XBRL document).</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; text-indent: 20pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
        behalf by the undersigned hereunto duly authorized.</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 30%; vertical-align: top; font-size: 10pt;"><br/>
            </td>

    <td style="vertical-align: bottom; font-size: 10pt;" colspan="2">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Rocket Pharmaceuticals, Inc.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 64.83%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Date: February 26, 2026</div>
            </td>

    <td style="width: 5%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">By:</div>
            </td>

    <td style="width: 64.83%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">/s/ Martin Wilson</div>
            </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 64.83%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Martin Wilson</div>
            </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 64.83%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">General Counsel and Chief Corporate Officer, SVP</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left;">
<div><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span></div>

        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    </div>

  </div>

  <div><span style="font-size: 10pt;"> </span></div>

</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ef20066645_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2026 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div>
        <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <font style="font-size: 10pt;">Exhibit 99.1<br>
          </font></div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <font style="font-size: 10pt;"><br>
          </font></div>
        <img src="image00001.jpg"></div>
      <div><font style="font-size: 10pt;"><br>
        </font>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Highlights Recent Progress</div>
      </div>
      <div style="text-align: center; font-size: 10pt;"><a name="OLE_LINK1"></a><a name="OLE_LINK2"></a><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Pivotal Phase 2 trial of RP-A501 for Danon disease to resume in 1H 2026</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">KRESLADI&#8482; for severe LAD-I on track for March 28, 2026 PDUFA date</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Dosing of first patient in Phase 1 study of RP-A701 for BAG3-related dilated cardiomyopathy anticipated in mid-2026</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Cash, cash equivalents and investments of approximately $188.9M;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">expected operational runway into the second quarter of 2027</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">CRANBURY, NJ </font><font style="font-size: 10pt;">&#8211; <font style="font-family: 'Times New Roman'; font-weight: bold;">February 26, 2026 </font>&#8211; <u>Rocket Pharmaceuticals, Inc.</u> (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with
          high unmet need, today reported financial and recent operational results for the fourth quarter and year ended December 31, 2025.</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;In 2025, we strengthened Rocket&#8217;s leadership in cardiovascular gene therapy, supported by more than five years of clinical experience in Danon disease and continued
        advancement across our PKP2-ACM and BAG3-DCM programs,&#8221; said Gaurav Shah, M.D., Chief Executive Officer of Rocket Pharmaceuticals. &#8220;Our focus remains on rigorous clinical execution across three cardiovascular programs, including resuming the Phase
        2 pivotal clinical trial in Danon disease, initiating the Phase 1 clinical trial in BAG3-DCM, and advancing alignment with the FDA on the pivotal study design for PKP2-ACM. As we move through 2026, Rocket is well positioned to advance three
        high-impact cardiovascular programs and thoughtfully expand our cardiac gene therapy pipeline.&#8221;</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Recent Pipeline and Operational Updates</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z07cc9caa635742cc9e355e95157cdfa5">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">Dosing of additional patients for the Phase 2 study of RP-A501 for Danon disease anticipated in the first half of 2026.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6ed642f80b134f09bf1f5d93ebbc0888">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">o</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">In August 2025, Rocket <u>disclosed</u> that the U.S. Food and Drug Administration&#8217;s (FDA) lifted the clinical hold on the Company&#8217;s pivotal Phase 2 trial of RP-A501 for the treatment of Danon
                disease in under three months.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zea953a23b519493392d482dad9ba8f09">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">o</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Per agreement with the FDA, three additional patients will be treated at a recalibrated dose of 3.8 &#215; 10&#185;&#179; GC/kg with a minimum four-week interval between dosing and a modified immunomodulatory
                regimen. Following the treatment of these three patients, Rocket will align with the FDA regarding the completion of the Phase 2 pivotal study.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5acbb3cd241f4fcca1cf33c42464179e">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">o</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Details of the Phase 2 pivotal study can be found at <u>www.ClinicalTrials.gov</u> under NCT identifier NCT06092034.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div><img src="image00001.jpg"><br>
          </div>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2c367b4f71754ce1a3f427df58e0a040">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">Engagement with the FDA is ongoing regarding RP-A601 for PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM).</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za55dae56367f452e8153537749e361ec">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">o</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Rocket continues to work closely with the FDA to advance alignment on a potential pivotal Phase 2 trial design for RP-A601 in PKP2-ACM, while the ongoing Phase 1 study remains open and actively
                enrolling to further characterize biological activity across a broader range of disease severity.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z88f16aec95a44ce4bcc0f0b0b6bf506e">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">o</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Details of the Phase 1 study can be found at <u>www.ClinicalTrials.gov</u> under NCT identifier NCT05885412.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0b79e1926a3744eda51d6ecbf821eb87">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">Phase 1 trial start-up activities are ongoing for RP-A701 in BAG3-associated dilated cardiomyopathy (BAG3-DCM).</div>
            </td>
          </tr>

      </table>
      <div>
        <div> <br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf136566c18d84353b8da37e429cb3e54">

            <tr>
              <td style="width: 54pt; font-size: 10pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">o</td>
              <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
                <div style="font-family: 'Times New Roman';">The first-in-human Phase 1 clinical trial will be a multi-center, dose-escalation study designed to evaluate the safety, biological activity, and preliminary efficacy of RP-A701 in adults with
                  BAG3-DCM. Rocket expects to dose the first BAG3-DCM patient mid-2026.</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zabb6e455255045d2b8efe0d9afe945d5">

            <tr>
              <td style="width: 54pt; font-size: 10pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">o</td>
              <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
                <div style="font-family: 'Times New Roman';">Details of the Phase 1 study can be found at <u>www.ClinicalTrials.gov</u> under NCT identifier NCT07137338.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0adace126c6e41eeaf263136ec269b98">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">FDA accepted the resubmission of the BLA for KRESLADI</font><font style="font-size: 10pt;"><sup style="font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup><font style="font-family: 'Times New Roman'; font-weight: bold;"> (marnetegragene autotemcel; marne-cel) for the treatment of severe leukocyte adhesion deficiency-I (LAD-I).</font></font></div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z67ea9742a9f046c0bada3fe7605b9a11">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">o</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">In October 2025, KRESLADI<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> <u>received</u> a Prescription Drug User Fee Act (PDUFA) target action date for March 28, 2026.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z496717bf5ae249e8b24f91d4c074709c">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">o</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Rocket is eligible for a Rare Pediatric Disease Priority Review Voucher (PRV), with the approval of KRESLADI&#8482;.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Fourth Quarter and Full Year 2025 Financial Results</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf94a2d5f6cae478b83ed7f92fc62af16">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Cash position. </font><font style="font-size: 10pt;">Cash, cash equivalents and investments as of
                  December 31, 2025, were $188.9 million.</font></div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfb1cef8e37634bb0bde4efd8d98c87da">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">R&amp;D expenses. </font><font style="font-size: 10pt;">Research and development expenses were
                  $142.0 million for the twelve months ended December 31, 2025, compared to $171.2 million for the twelve months ended December 31, 2024. The decrease of $29.2 million in R&amp;D expenses was primarily driven<font style="font-family: 'Times New Roman'; font-weight: bold;">&#160;</font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">by decreases in manufacturing and development and direct material costs of $10.8 million, professional fees of $7.0 million, lab
                    supplies and office expenses of $4.4 million, stock-based and other compensation and benefit expenses of $3.7 million, and clinical trial expenses of $2.7 million. The reduction reflects disciplined resource allocation following the
                    company&#8217;s recent organizational realignment.</font></font></div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7b38099bb8104543a2dad6f739d20047">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">G&amp;A expenses. </font><font style="font-size: 10pt;">General and administrative expenses were
                  $86.5 million for the twelve months ended December 31, 2025, compared to $102.0 million for the twelve months ended December 31, 2024. The decrease of $15.5 million in G&amp;A expenses was primarily driven by decreases in commercial
                  preparation-related expenses of $11.5 million from declining payroll and commercial launch services and stock-based and other compensation and benefit expenses of $5.4 million, partially offset by increase in legal expenses of $1.4
                  million.</font></div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1133582c73d74193a4440d81552d9b0d">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Net loss. </font><font style="font-size: 10pt;">Net loss was $223.1 million or $2.01 per share
                  (basic and diluted) for the twelve months ended December 31, 2025, compared to $258.7 million or $2.73 (basic and diluted) for the twelve months ended December 31, 2024.</font></div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div><img src="image00001.jpg"><br>
          </div>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd87fccffbd4647e09d1f774f536edff4">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Shares outstanding. </font><font style="font-size: 10pt;">108,319,783 shares of common stock were
                  outstanding as of December 31, 2025.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;">
        <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">Restructuring Expenses and Financial Guidance</div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd7a465c0d56c4c6e86f27f2cce32c330">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Restructuring expenses. </font><font style="font-size: 10pt;">Approximately $3.2 million in
                  restructuring and restructuring-related charges were incurred in 2025.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7beec944a1884ede82088c1e1670d411">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Cash position. </font><font style="font-size: 10pt;">As of December 31, 2025, Rocket had cash,
                  cash equivalents and investments of $188.9 million. Rocket expects such resources, excluding any potential future proceeds from a Priority Review Voucher that may be granted upon FDA approval of KRESLADI<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup>, will be sufficient
                  to fund its operations into the second quarter of 2027.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;">
        <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">About Rocket Pharmaceuticals, Inc.</div>
      </div>
      <div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of investigational genetic
          therapies designed to correct the root cause of complex and rare disorders. Rocket&#8217;s innovative multi-platform approach allows us to design the optimal gene therapy for each indication, creating potentially transformative options that enable
          people living with devastating rare diseases to experience long and full lives.</div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Rocket&#8217;s adeno-associated viral (AAV) vector-based cardiovascular portfolio includes a late-stage clinical program for Danon Disease, a devastating heart failure
          condition resulting in thickening of the heart, and an early-stage clinical program for PKP2-arrhythmogenic cardiomyopathy (ACM), a life-threatening heart failure disease causing ventricular arrhythmias and sudden cardiac death. Rocket has also
          received IND clearance for its AAV-based gene therapy for BAG3-associated dilated cardiomyopathy (DCM), a heart failure condition that causes enlarged ventricles.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Rocket&#8217;s lentiviral (LV) vector-based hematology portfolio consists of late-stage programs for Leukocyte Adhesion Deficiency-I (LAD-I), a severe pediatric genetic
          disorder that causes recurrent and life-threatening infections which are frequently fatal, Fanconi Anemia (FA), a difficult-to-treat genetic disease that leads to bone marrow failure (BMF) and potentially cancer, and Pyruvate Kinase Deficiency
          (PKD), a monogenic red blood cell disorder resulting in increased red cell destruction and mild to life-threatening anemia.</div>
        <div style="font-size: 10pt;"><br>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">For more information about Rocket, please visit <u>www.rocketpharma.com</u> and follow us on <u>LinkedIn</u>, <u>YouTube</u>, and <u>X</u><font style="font-family: 'Times New Roman';">.</font></div>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div><img src="image00001.jpg"><br>
          </div>
        </div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Rocket Cautionary Statement Regarding Forward-Looking Statements</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">This press release contains forward-looking statements concerning Rocket&#8217;s future expectations, plans and prospects that involve risks and uncertainties, as well as
        assumptions that, if they do not materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. We make such forward-looking statements pursuant to the safe harbor
        provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. All statements other than statements of historical facts contained in this release are forward-looking statements. You should not place reliance
        on these forward-looking statements, which often include words such as "believe," "expect," "anticipate," "intend," "plan," "will give," "estimate," "seek," "will," "may," "suggest" or similar terms, variations of such terms or the negative of
        those terms. These forward-looking statements include, but are not limited to, statements concerning Rocket&#8217;s expectations of our ability to obtain additional funding to conduct our planned research and development efforts, the expected timing and
        data readouts of Rocket&#8217;s ongoing and planned clinical trials, the expected timing and outcome of Rocket&#8217;s regulatory interactions and planned submissions, Rocket&#8217;s plans for the advancement of its cardiovascular AAV programs and KRESLADI<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup>,
        including its planned pivotal trials, and the safety, effectiveness and timing of related pre-clinical studies and clinical trials, Rocket&#8217;s ability to establish key collaborations and vendor relationships for its product candidates, Rocket&#8217;s
        ability to develop its direct manufacturing capabilities for its AAV programs, Rocket&#8217;s ability to develop sales and marketing capabilities or enter into agreements with third parties to sell and market its product candidates and Rocket&#8217;s ability
        to expand its pipeline to target additional indications that are compatible with its gene therapy technologies. Although Rocket believes that the expectations reflected in the forward-looking statements are reasonable, Rocket cannot guarantee such
        outcomes. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including, without limitation, Rocket&#8217;s dependence on third parties for development, manufacture,
        marketing, sales and distribution of product candidates, the outcome of litigation, unexpected expenditures, Rocket&#8217;s competitors&#8217; activities, including decisions as to the timing of competing product launches, pricing and discounting, Rocket&#8217;s
        ability to develop, acquire and advance product candidates into, enroll a sufficient number of patients into, and successfully complete, clinical studies, Rocket&#8217;s ability to acquire additional businesses, form strategic alliances or create joint
        ventures and its ability to realize the benefit of such acquisitions, alliances or joint ventures, our ability to achieve the expected benefits of our portfolio prioritization and strategic restructuring, including extending our cash runway, and
        our estimates related to the costs and timing of implementing such initiatives, Rocket&#8217;s ability to obtain and enforce patents to protect its product candidates, and its ability to successfully defend against unforeseen third-party infringement
        claims, as well as those risks more fully discussed in the section entitled "Risk Factors" in Rocket&#8217;s Annual Report on Form 10-K for the year ended December 31, 2025, filed February 26, 2026 with the SEC and subsequent filings with the SEC
        including our Quarterly Reports on Form 10-Q. Accordingly, you should not place undue reliance on these forward-looking statements. All such statements speak only as of the date made, and Rocket undertakes no obligation to update or revise publicly
        any forward-looking statements, whether as a result of new information, future events or otherwise.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div><img src="image00001.jpg"><br>
          </div>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" class="cfttable" id="zbd64dc9e5dfa4ad78ca9d263a3acb68c" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="6" style="vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Three Months Ended December 31,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="6" style="vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Twelve Months Ended December 31,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"> 2025</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">2024</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">2025</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">2024</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Operating expenses:</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: middle; font-size: 10pt;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: middle; font-size: 10pt;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: middle; font-size: 10pt;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: middle; font-size: 10pt;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; font-size: 10pt; width: 52%; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Research and development</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">29,347</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">37,357</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">142,015</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">171,244</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; font-size: 10pt; width: 52%;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">General and administrative</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">14,684</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">25,337</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">86,501</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">101,961</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; font-size: 10pt; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Restructuring</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(68</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">3,231</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; font-size: 10pt; width: 52%; padding-bottom: 2px;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Total operating expenses</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">43,963</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">62,694</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">231,747</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">273,205</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; font-size: 10pt; width: 52%; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Loss from operations</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(43,963</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(62,694</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(231,747</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(273,205</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; font-size: 10pt; width: 52%;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Interest expense</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(473</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(473</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(1,891</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(1,886</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; font-size: 10pt; width: 52%; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Interest and other income, net</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">690</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">1,617</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">3,218</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">8,267</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; font-size: 10pt; width: 52%; padding-bottom: 2px;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Accretion of discount on investments, net</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">1,208</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">1,223</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">7,297</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">8,078</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; font-size: 10pt; width: 52%; padding-bottom: 4px; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Net loss</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(42,538</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(60,327</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(223,123</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(258,746</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; font-size: 10pt; width: 52%; padding-bottom: 4px;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Net loss per share - basic and diluted</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(0.38</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(0.62</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(2.01</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(2.73</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; font-size: 10pt; width: 52%; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Weighted-average common shares outstanding - basic and diluted</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">111,787,305</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">97,530,032</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">111,123,770</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">94,807,773</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; width: 52%;">
              <div style="text-align: left; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;"><br>
            </td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; padding-bottom: 2px; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
              <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">December 31, 2025</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">December 31, 2024</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; padding-bottom: 2px;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; padding-bottom: 2px;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px;"><br>
            </td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; width: 52%;">
              <div style="text-align: left; font-family: 'Times New Roman';">Cash, cash equivalents, and investments</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">
              <div style="font-family: 'Times New Roman';">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;">
              <div style="font-family: 'Times New Roman';">188,929</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">
              <div style="font-family: 'Times New Roman';">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;">
              <div style="font-family: 'Times New Roman';">372,336</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;"><br>
            </td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; width: 52%; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Total assets</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">330,449</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">527,700</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;"><br>
            </td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; width: 52%;">
              <div style="text-align: left; font-family: 'Times New Roman';">Total liabilities</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;">
              <div style="font-family: 'Times New Roman';">53,228</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;">
              <div style="font-family: 'Times New Roman';">64,466</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;"><br>
            </td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; width: 52%; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Total stockholders' equity</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">277,221</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">463,234</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-size: 10pt; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;"><br>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;"><br>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Investors</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Meg Dodge</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><u>mdodge@rocketpharma.com</u></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Media</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Kevin Giordano</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><u>media@rocketpharma.com</u></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>rckt-20260226.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.10.1.5333 Broadridge-->
<xs:schema targetNamespace="http://rocketpharma.com/20260226" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:rckt="http://rocketpharma.com/20260226" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:srt-types="http://fasb.org/srt-types/2025">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="rckt-20260226_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="rckt-20260226_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://rocketpharma.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2025" schemaLocation="https://xbrl.sec.gov/exch/2025/exch-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2025" schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2025" schemaLocation="https://xbrl.sec.gov/sic/2025/sic-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2025" schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>rckt-20260226_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.10.1.5333 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>rckt-20260226_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.10.1.5333 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://rocketpharma.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="rckt-20260226.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://rocketpharma.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !5 ,(# 2(  A$! Q$!_\0
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M[IW8X('!SZ5]"D @@@$'@@UYGXD^"/@O7;Q[HV4UA/(=SFRD\M2?7;@J/P%
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%HHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 26, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 26,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Rocket Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001281895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3475813<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9 Cedarbrook Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cranbury<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">440-9100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RCKT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ef20066645_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rocketpharma.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ef20066645_8k.htm">ef20066645_8k.htm</File>
    <File>rckt-20260226.xsd</File>
    <File>rckt-20260226_lab.xml</File>
    <File>rckt-20260226_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20066645_8k.htm": {
   "nsprefix": "rckt",
   "nsuri": "http://rocketpharma.com/20260226",
   "dts": {
    "inline": {
     "local": [
      "ef20066645_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "rckt-20260226.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/exch/2025/exch-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/sic/2025/sic-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "rckt-20260226_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rckt-20260226_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://rocketpharma.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20260226to20260226",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20066645_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20260226to20260226",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20066645_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001140361-26-006981-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-26-006981-xbrl.zip
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MC/GFS;NUC:K[#*%)@^=5>^9*H^<.EZP/%W$NXU7%,98TV%_7751PS-*9[]#
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M.);?MVK_ ];=T^-440IO4KEJW7'<D\W1'B<]L_-I"R1!"1.*5/.06_WK]SV
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M^:);BN%3' P@&834Y&E"PNW>< P 9 F$7^";Y-NSF20LP1N8 %,7!#.6P9*
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M ?VY6IH^5[%X:H,-L:DC2\#4IM_@<9@*;:U%T>!E2M$L6 I^V2VN!".U@'D
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MUN=SAGYR7_^29T&Q02MQ:=1Z0]HP"G]BS0'L^)KZ"9:9'<F"#I'=5%OR@A)
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M="TR,#(V,#(R-E]L86(N>&UL4$L! A0#%     @ J():7(D\WL3@!0  ^CX
M !4              ( !+$   ')C:W0M,C R-C R,C9?<')E+GAM;%!+!08
1    !0 % $<!   _1@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>ef20066645_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rckt-20260226.xsd" xlink:type="simple"/>
    <context id="c20260226to20260226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001281895</identifier>
        </entity>
        <period>
            <startDate>2026-02-26</startDate>
            <endDate>2026-02-26</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20260226to20260226"
      id="Fact_e3e9eac808264ac2960927de8bc4242a">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20260226to20260226"
      id="Fact_acdd86df40cd4b2b8abb1f2b3226cc23">0001281895</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20260226to20260226"
      id="Fact_8710bd8f93954c14ae8d4d83c1765e32">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20260226to20260226"
      id="Fact_74990d4afd8b4a26bb3fe5763ea7602b">2026-02-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20260226to20260226"
      id="Fact_0075e3a30a964b1d923a1e9d4ea4e95c">Rocket Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20260226to20260226"
      id="Fact_30f7eedfb6ee455f8bf9bab923b106cf">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20260226to20260226"
      id="Fact_f6a54965804945cb98f677ae54b6fda1">001-36829</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20260226to20260226"
      id="Fact_6c732d4f9e434084a4a523c80788826b">04-3475813</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20260226to20260226"
      id="Fact_056294b47e544ea8a77dac2bb51c21e2">9 Cedarbrook Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20260226to20260226"
      id="Fact_2832b928e97b4a01a14589a7100ee904">Cranbury</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20260226to20260226"
      id="Fact_4af64b992fae46208162d2383585a736">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20260226to20260226"
      id="Fact_e33554e4daae484a9c37861c175f7873">08512</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20260226to20260226"
      id="Fact_f5d628e6546947c985f39da32c2b21de">646</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20260226to20260226"
      id="Fact_fbde6efd0640486393ea4ee8ce83f4e2">440-9100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20260226to20260226"
      id="Fact_48917a47bff547a183111e67f5cbd94a">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20260226to20260226"
      id="Fact_7aa612f292a54230b005aee4f5256503">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20260226to20260226"
      id="Fact_ff2482aa341c48ffa578d009fbaafe87">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20260226to20260226"
      id="Fact_38c746b3523b4939af131511deb23496">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20260226to20260226"
      id="Fact_eb846fb6afed4786a890f4e3485d53f4">Common stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20260226to20260226"
      id="Fact_515feaaf4d554b52aee0dd1ca957b245">RCKT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20260226to20260226"
      id="Fact_7ef7ce52996e424fbf8773bd11c4f080">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20260226to20260226"
      id="Fact_7120bd16dd83476c9b6a4b196125c36d">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
